OncoCyte Corporation OCX

Set alert

Price alert · OCX

All alert types
3.20 0.00 0.00%

At close · Jun 17

2.82 Day range 3.20

52-week range unavailable

YTD
+34.45%
1 year
+15.94%
Open
2.82
Prev close
3.20
Mkt cap
36.87M
Vol
100.56K
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
2.82
High
3.20
Forward P/E
-1.27
Beta
0.00
Short ratio
2.59
Inst. own
50.60%
Dividend
0.00
Ex-div date
Earnings
Mar 29, 2024
50-d avg
2.73
200-d avg
2.89
1y target
4.13

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for OCX has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-20.73 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -1.7×
FY 2016: -16.7×FY 2017: -7.2×FY 2018: -3.3×FY 2019: -5.2×FY 2020: -5.2×FY 2021: -3.0×FY 2022: -0.5×FY 2023: -0.7×FY 2024: -0.5×FY 2025: -1.7×
FY 2016 5y median -0.7× FY 2025
P/S 20.5×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 129×FY 2021: 25.0×FY 2022: 37.1×FY 2023: 12.7×FY 2024: 16.5×FY 2025: 20.5×
FY 2016 5y median 20.5× FY 2025
P/B -2.6×
FY 2016: 19.0×FY 2017: 31.9×FY 2018: 15.3×FY 2019: 3.7×FY 2020: 4.7×FY 2021: 3.0×FY 2022: 1.0×FY 2023: 0.7×FY 2024: -2.5×FY 2025: -2.6×
FY 2016 5y median 0.7× FY 2025
P/FCF -3.8×
FY 2016: -24.5×FY 2017: -10.4×FY 2018: -4.5×FY 2019: -5.6×FY 2020: -5.8×FY 2021: -5.1×FY 2022: -0.7×FY 2023: -0.8×FY 2024: -1.5×FY 2025: -3.8×
FY 2016 5y median -1.5× FY 2025
EV/EBITDA 34.2×
FY 2016: -15.9×FY 2017: -7.4×FY 2018: -3.0×FY 2019: -4.5×FY 2020: -5.2×FY 2021: -3.4×FY 2022: -1.4×FY 2023: -0.5×FY 2024: -0.4×FY 2025: 34.2×
FY 2016 5y median -0.5× FY 2025
EV/Sales 18.5×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 130×FY 2021: 21.1×FY 2022: 20.0×FY 2023: 8.4×FY 2024: 13.9×FY 2025: 18.5×
FY 2016 5y median 18.5× FY 2025
FCF Yield -26.7%
FY 2016: -4.1%FY 2017: -9.6%FY 2018: -22.4%FY 2019: -17.9%FY 2020: -17.4%FY 2021: -19.8%FY 2022: -140.3%FY 2023: -123.4%FY 2024: -68.2%FY 2025: -26.7%
FY 2016 5y median -68.2% FY 2025

Profitability

Gross Margin 56.7%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -52.5%FY 2021: 2.4%FY 2022: -1.9%FY 2023: 27.5%FY 2024: 39.3%FY 2025: 56.7%
FY 2016 5y median 27.5% FY 2025
Operating Margin -1260.8%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -2443.3%FY 2021: -607.6%FY 2022: -1878.6%FY 2023: -1672.4%FY 2024: -3245.1%FY 2025: -1260.8%
FY 2016 5y median -1672.4% FY 2025
Net Margin -1238.5%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -2461.5%FY 2021: -829.5%FY 2022: -7666.0%FY 2023: -1848.4%FY 2024: -3225.0%FY 2025: -1238.5%
FY 2016 5y median -1848.4% FY 2025
ROE 159.6%
FY 2016: -113.2%FY 2017: -440.0%FY 2018: -460.2%FY 2019: -72.4%FY 2020: -89.4%FY 2021: -98.3%FY 2022: -214.2%FY 2023: -108.5%FY 2024: 494.2%FY 2025: 159.6%
FY 2016 5y median -98.3% FY 2025
ROIC -330.1%
FY 2016: -107.4%FY 2017: -260.4%FY 2018: -275.0%FY 2019: -60.1%FY 2020: -57.4%FY 2021: -27.6%FY 2022: -20.3%FY 2023: -36.8%FY 2024: -209.8%FY 2025: -330.1%
FY 2016 5y median -36.8% FY 2025
ROA -195.0%
FY 2016: -77.3%FY 2017: -189.7%FY 2018: -165.5%FY 2019: -56.0%FY 2020: -54.0%FY 2021: -40.2%FY 2022: -73.4%FY 2023: -37.1%FY 2024: -172.9%FY 2025: -195.0%
FY 2016 5y median -73.4% FY 2025

Growth (YoY)

Revenue 115.6%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 535.4%FY 2022: -87.6%FY 2023: 56.9%FY 2024: 25.1%FY 2025: 115.6%
FY 2016 FY 2025
Operating Income 16.2%
FY 2016: -27.8%FY 2017: -69.2%FY 2018: 19.3%FY 2019: -46.3%FY 2020: -33.6%FY 2021: -58.0%FY 2022: 61.7%FY 2023: -39.7%FY 2024: -142.8%FY 2025: 16.2%
FY 2016 FY 2025
EPS (diluted) 64.6%
FY 2016: -1.2%FY 2017: -52.4%FY 2018: 35.2%FY 2019: -4.7%FY 2020: -4.9%FY 2021: -57.8%FY 2022: 8.0%FY 2023: 71.7%FY 2024: -24.3%FY 2025: 64.6%
FY 2016 FY 2025
Free Cash Flow -4.5%
FY 2016: -61.3%FY 2017: -76.7%FY 2018: 13.3%FY 2019: -76.7%FY 2020: -31.9%FY 2021: -40.4%FY 2022: -30.7%FY 2023: 52.7%FY 2024: 10.1%FY 2025: -4.5%
FY 2016 FY 2025

Financial Health

Current Ratio 1.3×
FY 2016: 3.0×FY 2017: 1.9×FY 2018: 1.6×FY 2019: 5.2×FY 2020: 1.0×FY 2021: 2.8×FY 2022: 2.1×FY 2023: 1.5×FY 2024: 1.6×FY 2025: 1.3×
FY 2016 5y median 1.6× FY 2025
Quick Ratio 1.2×
FY 2016: 3.0×FY 2017: 1.9×FY 2018: 1.6×FY 2019: 5.2×FY 2020: 1.0×FY 2021: 2.8×FY 2022: 2.1×FY 2023: 1.5×FY 2024: 1.6×FY 2025: 1.2×
FY 2016 5y median 1.6× FY 2025
Debt / Equity -0.1×
FY 2016: 0.1×FY 2017: 0.6×FY 2018: 0.5×FY 2019: 0.2×FY 2020: 0.3×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.1×FY 2024: -0.3×FY 2025: -0.1×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA -3.7×
FY 2016: 0.9×FY 2017: 0.3×FY 2018: 0.4×FY 2019: 0.7×FY 2020: -0.0×FY 2021: 0.6×FY 2022: 1.2×FY 2023: 0.3×FY 2024: 0.1×FY 2025: -3.7×
FY 2016 5y median 0.3× FY 2025
Interest Coverage 469×
FY 2016: -398×FY 2017: -86.9×FY 2018: -70.4×FY 2019: -74.4×FY 2020: -118×FY 2021: -225×FY 2022: -217×FY 2023: -483×FY 2024: -727×FY 2025: 469×
FY 2016 5y median -225× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.2%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: -0.6%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31